Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus
C. Furey, N. Ye, L. Kercher, J. DeBeauchamp, J. C. Crumpton, T. Jeevan, C. Patton, J. Franks, M.-G. Alameh, S. H. Y. Fan, A. T. Phan, C. A. Hunter, R. J. Webby, D. Weissman, S. E. Hensley
This study develops an mRNA vaccine against clade 2.3.4.4b H5 avian influenza virus and shows it is immunogenic and protective in mice and ferrets.
bioRxiv · Apr 30, 2023Microbiology